Takao Suzuki Selected Research

Hemorrhage

07/2008	The role of estrogen receptor subtypes on hepatic neutrophil accumulation following trauma-hemorrhage: Direct modulation of CINC-1 production by Kupffer cells.
04/2008	Mitogen activated protein kinase (MAPK) mediates non-genomic pathway of estrogen on T cell cytokine production following trauma-hemorrhage.
03/2008	Estrogen-mediated activation of non-genomic pathway improves macrophages cytokine production following trauma-hemorrhage.
01/2008	17beta-Estradiol's salutary effects on splenic dendritic cell functions following trauma-hemorrhage are mediated via estrogen receptor-alpha.
09/2007	Estrogen receptor-alpha predominantly mediates the salutary effects of 17beta-estradiol on splenic macrophages following trauma-hemorrhage.
09/2007	Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of the PI-3K/Akt pathway.
06/2007	The role of estrogen receptor subtypes in ameliorating hepatic injury following trauma-hemorrhage.
06/2007	The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage.
06/2007	Salutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor-alpha.
04/2007	G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage.
02/2007	Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway.
01/2007	Tissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage.
09/2006	Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage.
08/2006	Androstenediol administration after trauma-hemorrhage attenuates inflammatory response, reduces organ damage, and improves survival following sepsis.
08/2006	17 beta-estradiol administration following trauma-hemorrhage prevents the increase in Kupffer cell cytokine production and MAPK activation predominately via estrogen receptor-alpha.
07/2006	A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage.
06/2006	Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage.
05/2006	Salutary effects of estrogen receptor-beta agonist on lung injury after trauma-hemorrhage.
05/2006	Tissue-specific expression of estrogen receptors and their role in the regulation of neutrophil infiltration in various organs following trauma-hemorrhage.
04/2006	Androstenediol ameliorates alterations in immune cells cytokine production capacity in a two-hit model of trauma-hemorrhage and sepsis.
03/2006	Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expression.

Articles by Research Topic

Disease

22	Wounds and Injuries (Trauma) 07/2008 - 01/2006
21	Hemorrhage 07/2008 - 03/2006
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2008 - 01/2002
2	Neoplasms (Cancer) 10/2006 - 02/2002
2	Sepsis (Septicemia) 08/2006 - 04/2006
1	Neutropenia 04/2008
1	Cervical Intraepithelial Neoplasia 03/2008
1	Endometriosis (Adenomyosis) 01/2008
1	Clear Cell Adenocarcinoma 01/2008
1	Hemorrhagic Shock 01/2006
1	Shock 01/2006
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2005
1	Seminoma 02/2005
1	Acute Kidney Failure (Acute Renal Failure) 09/2004
1	Stomach Neoplasms (Stomach Cancer) 07/2003
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2003
1	Coma (Comas) 03/2003
1	Tooth Loss 01/2003
1	Postmenopausal Osteoporosis 01/2003
1	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 04/2002
1	Osteoporosis 01/2002
1	Hepatitis B 01/2002

Drug/Important Bio-Agent (IBA)

9	Estrogens (Estrogen)FDA Link 07/2008 - 01/2007
4	Estrogen Receptor alphaIBA 01/2008 - 08/2006
4	Estrogen Receptor betaIBA 09/2006 - 01/2006
3	AndrostenediolIBA 08/2006 - 04/2006
2	Estradiol (Estrace)FDA LinkGeneric 08/2006 - 03/2006
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2006 - 01/2006
2	Thymidine PhosphorylaseIBA 04/2002 - 01/2002
1	Protein Kinases (Protein Kinase)IBA 04/2008
1	Itraconazole (Sporanox)FDA LinkGeneric 04/2008
1	Keratin-8 (Keratin 8)IBA 03/2008
1	Keratin-17 (Keratin 17)IBA 03/2008
1	kalininIBA 01/2008
1	Peroxidase (Myeloperoxidase)IBA 09/2007
1	GTP-Binding Proteins (G-Protein)IBA 04/2007
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 04/2007
1	Flutamide (Eulexin)FDA LinkGeneric 02/2007
1	CurcuminIBA 10/2006
1	PPAR gammaIBA 07/2006
1	Estrogen ReceptorsIBA 05/2006
1	Valproic Acid (Valproate, Semisodium)FDA LinkGeneric 11/2005
1	Codon (Codons)IBA 02/2005
1	Natriuretic PeptidesIBA 09/2004
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2003
1	matrix Gla proteinIBA 01/2003
1	Adenosine Triphosphate (ATP)IBA 04/2002
1	Collagen Type I (Type I Collagen)IBA 02/2002
1	OsteoprotegerinIBA 01/2002
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2002
1	Carbon MonoxideIBA 01/2002

Therapy/Procedure

1	Lymph Node Excision (Lymph Node Dissection) 07/2003
1	Liver Transplantation 03/2003
1	Transplantation (Transplant Recipients) 01/2002